132 related articles for article (PubMed ID: 11152370)
1. Positive inotropic effects of calcium sensitizers on normal and failing cardiac myocytes.
Tsutsui H; Kinugawa S; Ide T; Hayashidani S; Suematsu N; Satoh S; Nakamura R; Egashira K; Takeshita A
J Cardiovasc Pharmacol; 2001 Jan; 37(1):16-24. PubMed ID: 11152370
[TBL] [Abstract][Full Text] [Related]
2. Effects of the Ca2+ sensitizers EMD 57033 and CGP 48506 on myocardial contractility and Ca2+ transients in human ventricular and atrial myocardium.
Brixius K; Reicke S; Reuter H; Schwinger RH
Z Kardiol; 2002 Apr; 91(4):312-8. PubMed ID: 12063703
[TBL] [Abstract][Full Text] [Related]
3. Positive inotropic effect of insulin-like growth factor-1 on normal and failing cardiac myocytes.
Kinugawa S; Tsutsui H; Ide T; Nakamura R; Arimura K; Egashira K; Takeshita A
Cardiovasc Res; 1999 Jul; 43(1):157-64. PubMed ID: 10536700
[TBL] [Abstract][Full Text] [Related]
4. Ca2+ sensitization in idiopathic dilated human myocardium. Differential in vitro effects of (+)-(5-methyl-6-phenyl)-1,3,5,6-tetrahydro-3,6-methano-1,5-benzodiazoci ne-2,4-dione, a novel purely Ca2+sensitizing agent, and (+)-5-(1-(3,4-dimethoxybenzoyl)-1,2,3,4-tetrahydroquinolin-6-yl)-6-meth yl-3, 6-dihydro-2H-1,3,4-thiadiazin-2-one on skinned fibres and isolated ventricular strips.
Herzig JW; Chiesi M; Depersin H; Grüninger S; Hasenfuss G; Kubalek R; Leutert T; Pieske B; Pioch K; Wenk P; Holubarsch C
Arzneimittelforschung; 1996 Jun; 46(6):586-93. PubMed ID: 8767348
[TBL] [Abstract][Full Text] [Related]
5. [The Ca(2+) sensitizers CGP 48506 and EMD 57033, but not the Na(+) channel modulator BDF 9148, prolong relaxation in isolated cardiomyocytes of the guinea pig].
Brixius K; Hoischen S; Zobel C; Lasek K; Schwinger RH
Z Kardiol; 2001 Apr; 90(4):286-91. PubMed ID: 11381577
[TBL] [Abstract][Full Text] [Related]
6. CGP-48506 increases contractility of ventricular myocytes and myofilaments by effects on actin-myosin reaction.
Wolska BM; Kitada Y; Palmiter KA; Westfall MV; Johnson MD; Solaro RJ
Am J Physiol; 1996 Jan; 270(1 Pt 2):H24-32. PubMed ID: 8769730
[TBL] [Abstract][Full Text] [Related]
7. Effects of Ca2+ sensitizers on contraction, [Ca2+]i transient and myofilament Ca2+ sensitivity in diabetic rat myocardium: potential usefulness as inotropic agents.
Ishitani T; Hattori Y; Sakuraya F; Onozuka H; Makino T; Matsuda N; Gando S; Kemmotsu O
J Pharmacol Exp Ther; 2001 Aug; 298(2):613-22. PubMed ID: 11454923
[TBL] [Abstract][Full Text] [Related]
8. Different effect of the Ca(2+) sensitizers EMD 57033 and CGP 48506 on cross-bridge cycling in human myocardium.
Brixius K; Mehlhorn U; Bloch W; Schwinger RH
J Pharmacol Exp Ther; 2000 Dec; 295(3):1284-90. PubMed ID: 11082466
[TBL] [Abstract][Full Text] [Related]
9. Cardiac Ca2+ signaling and Ca2+ sensitizers.
Endoh M
Circ J; 2008 Dec; 72(12):1915-25. PubMed ID: 18981594
[TBL] [Abstract][Full Text] [Related]
10. Improved mechanoenergetics and cardiac rest and reserve function of in vivo failing heart by calcium sensitizer EMD-57033.
Senzaki H; Isoda T; Paolocci N; Ekelund U; Hare JM; Kass DA
Circulation; 2000 Mar; 101(9):1040-8. PubMed ID: 10704173
[TBL] [Abstract][Full Text] [Related]
11. Different chronotropic and inotropic effects of EMD 57033 and EMD 53998, Ca2+ sensitizers, on isolated, blood-perfused dog heart preparations.
Lakhe M; Furukawa Y; Yonezawa T; Hirose M; Nagashima Y; Miyashita Y; Chiba S
Jpn J Pharmacol; 1998 Apr; 76(4):435-9. PubMed ID: 9623723
[TBL] [Abstract][Full Text] [Related]
12. Enantiomeric dissection of the effects of the inotropic agent, EMD 53998, in single cardiac myocytes.
Gambassi G; Capogrossi MC; Klockow M; Lakatta EG
Am J Physiol; 1993 Mar; 264(3 Pt 2):H728-38. PubMed ID: 8384421
[TBL] [Abstract][Full Text] [Related]
13. Effects of EMD 57033 on contraction and relaxation in isolated rabbit hearts.
Hgashiyama A; Watkins MW; Chen Z; LeWinter MM
Circulation; 1995 Nov; 92(10):3094-104. PubMed ID: 7586281
[TBL] [Abstract][Full Text] [Related]
14. A novel positive inotropic substance enhances contractility without increasing the Ca2+ transient in rat myocardium.
Ferroni C; Hano O; Ventura C; Lakatta EG; Klockow M; Spurgeon H; Capogrossi MC
J Mol Cell Cardiol; 1991 Mar; 23(3):325-31. PubMed ID: 1880816
[TBL] [Abstract][Full Text] [Related]
15. EMD 53998 acts as Ca(2+)-sensitizer and phosphodiesterase III-inhibitor in human myocardium.
Uhlmann R; Schwinger RH; Lues I; Erdmann E
Basic Res Cardiol; 1995; 90(5):365-71. PubMed ID: 8585857
[TBL] [Abstract][Full Text] [Related]
16. In vivo evidence of positive inotropism of EMD 57033 through calcium sensitization.
Haeusler G; Jonas R; Minck KO; Schliep HJ; Schelling P; Weygandt H; Lues I
J Cardiovasc Pharmacol; 1997 May; 29(5):647-55. PubMed ID: 9213208
[TBL] [Abstract][Full Text] [Related]
17. Functional effects of EMD-57033 in isovolumically beating isolated rabbit hearts.
Tobias AH; Slinker BK; Kirkpatrick RD; Campbell KB
Am J Physiol; 1996 Jul; 271(1 Pt 2):H51-8. PubMed ID: 8760157
[TBL] [Abstract][Full Text] [Related]
18. Effects of Ca2+ -sensitizers in permeabilized cardiac myocytes from donor and end-stage failing human hearts.
Papp Z; Van Der Velden J; Borbély A; Edes I; Stienen GJ
J Muscle Res Cell Motil; 2004; 25(3):219-24. PubMed ID: 15467385
[TBL] [Abstract][Full Text] [Related]
19. Overall cardiac functional effect of positive inotropic drugs with differing effects on relaxation.
Slinker BK; Wu Y; Green HW; Kirkpatrick RD; Campbell KB
J Cardiovasc Pharmacol; 2000 Jul; 36(1):1-13. PubMed ID: 10892654
[TBL] [Abstract][Full Text] [Related]
20. The two mechanisms of action of racemic cardiotonic EMD 53998, calcium sensitization and phosphodiesterase inhibition, reside in different enantiomers.
Lues I; Beier N; Jonas R; Klockow M; Haeusler G
J Cardiovasc Pharmacol; 1993 Jun; 21(6):883-92. PubMed ID: 7687712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
